These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1496542)

  • 1. Binding of phycoerythrin-conjugated interleukin-6 to in vitro-activated human peripheral blood mononuclear cells--effect of immunosuppressive agents and of a calcium channel blocker.
    Degiannis D; Luke-Gustites D; Mikhail N; Raska K; Raskova J
    Transplantation; 1992 Aug; 54(2):308-12. PubMed ID: 1496542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of verapamil on the IL-2 binding to its active receptor and on the release of IL-2 receptor by activated PBMC.
    Mikhail N; Raska K; Raskova J; Degiannis D
    Immunopharmacology; 1993; 25(1):29-36. PubMed ID: 8320080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal-dependent pleiotropic regulation of lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3: potent modulation of the hormonal effects by phorbol esters.
    Hustmyer FG; Girasole G; Manolagas SC
    Immunology; 1992 Dec; 77(4):520-6. PubMed ID: 1493924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-2 responsiveness of lectin-induced lymphoblasts: soluble IL-2 receptor release and differential in vitro effects of immunosuppressants.
    Hornung N; Raskova J; Raska K; Degiannis D
    Int J Immunopharmacol; 1992 Jul; 14(5):753-60. PubMed ID: 1512072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth, interleukin-2 production, and responsiveness to IL-2 in T4-positive T Lymphocyte populations from malignant cutaneous T cell lymphoma (Sézary's syndrome): the effect of cyclosporin A.
    Solbach W; Lange CE; Röllinghoff M; Wagner H
    Blood; 1984 Nov; 64(5):1022-7. PubMed ID: 6237693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phorbol myristate acetate (PMA) and ionophore A23187 on interleukin-2 levels and proliferation of activated T lymphocytes from patients with lepromatous leprosy.
    Alfaro-Bustamante F; Ramirez-Flores G; Gonzalez-Mendoza A; Islas-Rodriguez A; Fafutis-Morris M
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):73-9. PubMed ID: 9207756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-color flow cytometry detection of intracellular cytokines in peripheral blood mononuclear cells: comparative analysis of phorbol myristate acetate-ionomycin and phytohemagglutinin stimulation.
    Baran J; Kowalczyk D; Ozóg M; Zembala M
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):303-13. PubMed ID: 11238213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin inhibits the in vitro release of soluble interleukin-2 receptor by activated peripheral blood mononuclear cells (PBMC) independently of the mode of activation.
    Degiannis D; Hornung N
    Int J Immunopharmacol; 1995 Jul; 17(7):593-6. PubMed ID: 8586487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preovulatory human follicular fluid in vitro inhibits interleukin (IL)-1 alpha, IL-2, and production and expression of p55 chain IL-2 receptor of lymphomonocytes.
    Macciò A; Mantovani G; Turnu E; Artini P; Contu G; Volpe A
    Fertil Steril; 1994 Aug; 62(2):327-32. PubMed ID: 8034080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of immunosuppressive agents FK 506 and cyclosporin and steroids on the expression of IL-6 and its receptor by stimulated lymphocytes and monocytes.
    Moutabarrik A; Nakanishi I; Takahara S; Hachim K; Bengahnem MG; Ramadani B; Ishibashi M; Zaid D
    Transpl Int; 1994; 7 Suppl 1():S552-5. PubMed ID: 11271305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A blocks calcium-dependent pathways of gene activation.
    Baldari CT; Macchia G; Heguy A; Melli M; Telford JL
    J Biol Chem; 1991 Oct; 266(28):19103-8. PubMed ID: 1655771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma.
    Levesque MC; Haynes BF
    J Immunol; 2001 Jan; 166(1):188-96. PubMed ID: 11123292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infection.
    Allouche M; Lunardi-Iskandar Y; Varela-Millot C; Itzhaki M; Cornuet P; Meyer P; Jasmin C; Georgoulias V
    Clin Exp Immunol; 1990 Aug; 81(2):200-6. PubMed ID: 1696861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A does not inhibit the PHA-stimulated increase in intracellular Ca2+ concentration but inhibits the increase in E-rosette receptor (CD2) expression and appearance of interleukin-2 receptors (CD25).
    Redelman D
    Cytometry; 1988 Mar; 9(2):156-63. PubMed ID: 2896111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W; Reed JC; Nowell PC; Kamoun M
    J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of interleukin-4 and interleukin-13 secretion from human peripheral blood mononuclear cells.
    Luttmann W; Sengler C; Herzog V; Balkow S; Matthys H; Virchow JC
    Immunol Lett; 1999 Aug; 69(2):225-31. PubMed ID: 10482356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitogenic response of human thymocytes: identification of functional Ca2+-dependent and independent signals.
    Roifman CM; Mills GB; Cheung RK; Gelfand EW
    Clin Exp Immunol; 1986 Oct; 66(1):139-49. PubMed ID: 3100117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory effects of cytokines and cyclosporine A on peripheral blood mononuclear cells from stable multiple sclerosis patients.
    Guillen C; Prieto A; Alvarez-Cermeño JC; de la Piedra M; Gimeno A; Alvarez-Mon M
    Immunopharmacol Immunotoxicol; 1999 Aug; 21(3):527-49. PubMed ID: 10466078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro correction of the interleukin-2 and interferon-gamma defect in multiple sclerosis.
    Vervliet G; Schandené L
    Clin Exp Immunol; 1985 Sep; 61(3):556-61. PubMed ID: 3935348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of catalase on the proliferation of human lymphocytes to phorbol myristate acetate.
    Sagone AL; Husney R; Guter H; Clark L
    J Immunol; 1984 Sep; 133(3):1488-94. PubMed ID: 6747295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.